Hemodialysis Complication Clinical Trial
Official title:
Physiological and Psychological Impact of Mindfulness Meditation Practice on Chronic Hemodialysis Patients
Verified date | January 2017 |
Source | Hospital Israelita Albert Einstein |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This protocol of meditation is based on mindfulness program proposes to train meditation during the hemodialysis session. The investigators hypothesize that this program offered during hemodialysis session may promote well-being, reduce symptoms of stress and depression reported by the patients, which ultimately may improve biochemical parameters resulting from better adherence to treatment. Objectives: To evaluate the effects of mindfulness meditation practice in patients on chronic hemodialysis, in order to verify if this training can improve symptoms of depression, stress, quality of life and sleep disturbances. Methods: fifty patients will be separated in two groups, twenty five each group, half of them in the control group (CG) and the other half to the intervention group (IG). The patients will be evaluated pre- and pos-protocol.
Status | Enrolling by invitation |
Enrollment | 50 |
Est. completion date | June 30, 2018 |
Est. primary completion date | March 1, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion Criteria: - Be a patient at Einstein Dialysis Center - Have signed the informed consent Exclusion Criteria: - Have not signed the informed consent |
Country | Name | City | State |
---|---|---|---|
Brazil | Erika Bevilaqua Rangel | Sao Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
Hospital Israelita Albert Einstein |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement of symptoms of depression, stress, quality of life, sleep disorders, biochemical parameters resulting from better adherence to treatment | MAAS (Mindful Attention Awareness Scale): Self-report instrument that aims to measure individual differences in the frequency of states of consciousness and mind through time. The greater the more traces of attention (score 15-90). |
up to 12 months | |
Primary | Improvement of symptoms of quality of life | KDQOL (Kidney Disease Quality of Life): Evaluates the perception of quality of life related to renal disease. The closer to 100 the better the perception of quality of life (Score 0-100 on each item- 24 items) | up to 12 months | |
Primary | Improvement of symptoms of depression | BDI (Beck Depression Inventory): From 10 to 18 = mild to moderate depression; From 19 to 29 = moderate to severe depression; From 30 to 63 = severe depression |
up to 12 months | |
Primary | Improvement of symptoms of sleep disorders | PSQI (Pittsburgh Sleep Quality Index): Provides a measure of standardized sleep quality, the higher the score, the worse the quality of sleep, PSQI> 5 indicates that the individual is experiencing major difficulties in at least 2 components, or moderate difficulties in more than 3 components |
up to 12 months | |
Primary | Improvement of symptoms of stress | PSS (Perceived Stress Scale): Evaluates perceived stress, the greater the more perceived stress (score 0-40). |
up to 12 months | |
Primary | Improve symptoms of depression and stress | SCS (Self-Compassion Scale): The answers are given on a likert scale (1- "almost never" to 5 "almost always"), when the answers are not compassionate they must be calculated inversely. The scale is subdivided into 6 sub-scales of each of the three mechanisms in their positive and negative characteristics (mindfulness vs. over-identification, self-kindness versus self-judgment, and common humanity vs. isolation). "Global self-pity scores were calculated by inversely encoding the items of self-judgment, isolation, and over-identification, adding up to the six sub-scales. |
up to 12 months | |
Primary | Assessment of comorbidities | ICED (Index of coexistent diseases): The utilization of ICED enables stratifying the dialysis patients according to severity of their comorbidities and it is useful to identify the patients with a greater risk of death and hospitalization, as well as to aid in the forecast of and optimization of resources necessary for their treatment. The ICED aggregates the presence and severity of 19 medical conditions and 11 physical impairments within two scales: the Index of Disease Severity (IDS) and the Index of Physical Impairment (IPI). The final ICED score is determined by an algorithm combining the peak scores for the IDS and IPI. The range of the ICED is from 0 to 3, reflecting increasing severity ( 0 - normal, 1 - mild, 2- moderate, 3- severe). | up to 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05980845 -
The Effect Nature Sounds and Music on Hemodialysis Patients
|
N/A | |
Recruiting |
NCT05020717 -
Retrospective Survey of Hyperkalemia in Hemodialysis
|
||
Recruiting |
NCT04046042 -
Virtual Reality Intradialysis: Last vs. First Part of the Session
|
N/A | |
Recruiting |
NCT04094038 -
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT03311581 -
The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery
|
Phase 1 | |
Completed |
NCT05531175 -
REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS
|
N/A | |
Completed |
NCT04057313 -
Coffee in Hemodialysis and Headache
|
N/A | |
Completed |
NCT03061552 -
Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life
|
N/A | |
Completed |
NCT03251573 -
The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
|
||
Completed |
NCT03527680 -
Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis
|
N/A | |
Completed |
NCT05568342 -
The Effect of Roy Adaptation-Based Nursing Intervention
|
N/A | |
Completed |
NCT04063423 -
Non- Clinical Coagulation Activation During Hemodialysis
|
||
Active, not recruiting |
NCT06203795 -
Dialysis Performance of the FX CorAL Membrane
|
N/A | |
Completed |
NCT04319328 -
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
|
||
Completed |
NCT03627884 -
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
|
Phase 4 | |
Completed |
NCT05132036 -
Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients
|
N/A | |
Completed |
NCT03076528 -
An Innovative Virtually Supervised Exercise for Dialysis Patients
|
Phase 2 | |
Completed |
NCT06098443 -
Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis
|
N/A | |
Completed |
NCT04645121 -
Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
|
||
Recruiting |
NCT04127877 -
Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients
|
N/A |